New Nissan Leaf gets more range, but is it enough?

September 6, 2017
DETROIT (AP) — Nissan is turning over a new Leaf, adding 43 miles (69 kilometers) of range to the world's top-selling electric car while dropping its price to undercut Tesla's Model 3 and the Chevrolet Bolt. But the new Leaf, due out in the U.S. early next year, won't be able to match its prime competitors in terms of range —...
Advertisement

Related Videos


AutoMotoTV -   ▶  00:36



AutoMotoTV -   ▶  00:33



AutoMotoTV -   ▶  01:28


Recent related news

Nissan is slowly but surely seeing the title of the global best-selling electric model drifting away from its LEAF model, but since the Japanese carmaker is...
9 hours ago • autoevolution

Family Zone Cyber Safety Ltd (ASX:FZO) is continuing to build its base of contracted and recurring revenue. As at the end of January 2018, the company has...
17 hours ago • Proactive Investors

Improved aspects of the Nissan Leaf are hoped to draw motorists to electric cars
11 hours ago • West Briton

ST. PAUL, Minn.--(BUSINESS WIRE)--Ecolab Inc. (NYSE:ECL): FOURTH QUARTER HIGHLIGHTS: Reported diluted EPS $1.93, +56%; includes a $0.55 net discrete tax benefit...
8 hours ago • Business Wire

The DuPont™ Danisco® POWERBake® 6000 Dough Strengthener Product Range Offers the Versatility to Enhance Blends NEW CENTURY, Kan. (PRWEB) February 20,...
9 hours ago • PRWeb

CHICAGO (AP) — The U.S. Postal Service and the Chicago Chinatown Chamber of Commerce are unveiling a new stamp to help celebrate the Lunar New Year. The Year...
11 hours ago • Seattle Times

Honolulu has failed to make the top 25 in a new livability ranking of U.S. state capitals. Hawaii's state capital ranked 28th in WalletHub's new "2018's Best...
4 hours ago • bizjournals

The mystery surrounding strange symptoms of illness experienced by at least two dozen U.S. diplomats stationed in Havana has still not been resolved, The Los...
23 hours ago • WorldNews

Immuron Limited’s (ASX:IMC) (NASDAQ:IMRN) flag-ship product Travelan® has achieved a revenue in excess of $914,000 for the first six months of FY2018,...
5 days ago • Proactive Investors

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq:ACOR) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing...
11 hours ago • Business Wire

You might like